Biogen Inc (BIIB) stock news · rev $9.89B
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
This BIIB news page leads with what Biogen Inc filed — not a scraped headline mill.
No cached 8-K sentence for BIIB yet. We will not pad this page with generic market recap.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BIIB stock page; for the tape open the quote page.
BIIB stock news FAQ
What are BIIB's latest revenue and net income?
Latest cached Biogen Inc (BIIB) revenue for Dec 31, 2025 was $9.89B. Net income was $1.29B. Statements: https://lician.com/financials/biib
How did BIIB revenue change from the prior cached period?
Cached Biogen Inc (BIIB) revenue was up 2.2% from $9.68B (Dec 31, 2024) to $9.89B (Dec 31, 2025). Statements: https://lician.com/financials/biib
What is BIIB's market cap?
Biogen Inc (BIIB) market cap is $29.33B on the latest cached fundamentals snapshot.
What kind of company is BIIB?
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Where is BIIB stock news listed?
Cached stock news for Biogen Inc (BIIB) is listed at https://lician.com/news/biib. Filings: https://lician.com/sec/biib
Not investment advice.